Globitair

Leader meetingsStock market

Summit Therapeutics Jumps on $2 Billion AstraZeneca Investment

Bloomberg

Summit Therapeutics Inc. shares rose after it said AstraZeneca Plc would make a $2 billion strategic equity investment in the cancer drugmaker to jointly develop drugs.

Read the full story at BloombergOpen in the live monitor

Related discussion groups

No group discusses this yet. Start a discussion group and attach this story.

More on Leader meetings